Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018

SELL
$27.45 - $33.35 $18,446 - $22,411
-672 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$29.15 - $37.4 $13,409 - $17,204
-460 Reduced 40.64%
672 $21,000
Q4 2017

Jan 25, 2018

BUY
$24.55 - $36.3 $7,954 - $11,761
324 Added 40.1%
1,132 $40,000
Q3 2017

Nov 01, 2017

BUY
$22.55 - $28.1 $18,220 - $22,704
808
808 $22,000

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.